TYRA BIOSCIENCES INC's ticker is and the CUSIP is 90240B106. A total of 50 filers reported holding TYRA BIOSCIENCES INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.7%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $11,815 | +5.4% | 858 | +30.4% | 0.00% | – |
Q2 2023 | $11,205 | +44720.0% | 658 | -57.4% | 0.00% | -100.0% |
Q1 2023 | $25 | +78.6% | 1,546 | -18.3% | 0.00% | 0.0% |
Q4 2022 | $14 | -100.0% | 1,893 | -55.0% | 0.00% | 0.0% |
Q3 2022 | $37,000 | +76.2% | 4,203 | +43.1% | 0.00% | – |
Q2 2022 | $21,000 | +61.5% | 2,937 | +136.3% | 0.00% | – |
Q1 2022 | $13,000 | -7.1% | 1,243 | +29.1% | 0.00% | – |
Q4 2021 | $14,000 | – | 963 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Canaan Partners XI LLC | 4,409,991 | $31,531,000 | 11.23% |
Nextech Invest Ltd. | 2,518,582 | $18,008,000 | 6.07% |
Boxer Capital, LLC | 6,448,359 | $46,106,000 | 2.92% |
TCG Crossover Management, LLC | 896,418 | $6,409,000 | 2.72% |
Fairmount Funds Management LLC | 1,416,998 | $10,132,000 | 2.32% |
RA Capital Management | 7,236,454 | $51,741,000 | 1.38% |
Frazier Life Sciences Management, L.P. | 1,375,065 | $9,832,000 | 0.93% |
BVF INC/IL | 2,472,327 | $17,677,000 | 0.85% |
Sio Capital Management, LLC | 152,159 | $1,088,000 | 0.41% |
Cormorant Asset Management, LP | 743,988 | $5,320,000 | 0.40% |